These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


321 related items for PubMed ID: 1894196

  • 1. Structure-function and refolding studies of the thrombin-specific inhibitor hirudin.
    Johnson PH, Sze P, Winant RC, Hudson D, Underhill P, Lazar JB, Olsen C, Almquist R.
    Haemostasis; 1991; 21 Suppl 1():41-8. PubMed ID: 1894196
    [Abstract] [Full Text] [Related]

  • 2. Structure-activity relationships of recombinant hirudins.
    Stürzebecher J, Walsmann P.
    Semin Thromb Hemost; 1991 Apr; 17(2):94-8. PubMed ID: 1771418
    [Abstract] [Full Text] [Related]

  • 3. Structure-function relationships of the C-terminal functional domain of hirudin and its variants.
    Krstenansky JL, Mao SJ.
    Blood Coagul Fibrinolysis; 1991 Feb; 2(1):91-6. PubMed ID: 1773003
    [Abstract] [Full Text] [Related]

  • 4. Thrombin inhibition by hirudin: how hirudin inhibits thrombin.
    Fenton JW, Villanueva GB, Ofosu FA, Maraganore JM.
    Haemostasis; 1991 Feb; 21 Suppl 1():27-31. PubMed ID: 1894193
    [Abstract] [Full Text] [Related]

  • 5. Production, properties, and thrombin inhibitory mechanism of hirudin amino-terminal core fragments.
    Chang JY.
    J Biol Chem; 1990 Dec 25; 265(36):22159-66. PubMed ID: 2266119
    [Abstract] [Full Text] [Related]

  • 6. Use of fragments of hirudin to investigate thrombin-hirudin interaction.
    Dennis S, Wallace A, Hofsteenge J, Stone SR.
    Eur J Biochem; 1990 Feb 22; 188(1):61-6. PubMed ID: 2180697
    [Abstract] [Full Text] [Related]

  • 7. Mechanism of the inhibition of alpha-thrombin by hirudin-derived fragments hirudin(1-47) and hirudin(45-65).
    Schmitz T, Rothe M, Dodt J.
    Eur J Biochem; 1991 Jan 01; 195(1):251-6. PubMed ID: 1991472
    [Abstract] [Full Text] [Related]

  • 8. CX-397, a novel recombinant hirudin analog having a hybrid sequence of hirudin variants-1 and -3.
    Komatsu Y, Misawa S, Sukesada A, Ohba Y, Hayashi H.
    Biochem Biophys Res Commun; 1993 Oct 29; 196(2):773-9. PubMed ID: 8240353
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of thrombin by synthetic hirudin peptides.
    Binnie CG, Erickson BW, Hermans J.
    FEBS Lett; 1990 Sep 17; 270(1-2):85-9. PubMed ID: 2226793
    [Abstract] [Full Text] [Related]

  • 10. Probing the hirudin-thrombin interaction by incorporation of noncoded amino acids and molecular dynamics simulation.
    De Filippis V, Colombo G, Russo I, Spadari B, Fontana A.
    Biochemistry; 2002 Nov 19; 41(46):13556-69. PubMed ID: 12427016
    [Abstract] [Full Text] [Related]

  • 11. Inhibition of in vitro clot growth by r-hirudin is more effective and longer sustained than by an analogous peptide.
    Römisch J, Stöhr HA, Stauss H, Koschinsky R, Stüber W, Pâques EP.
    Thromb Haemost; 1994 Mar 19; 71(3):320-4. PubMed ID: 8029796
    [Abstract] [Full Text] [Related]

  • 12. Thermodynamic investigation of hirudin binding to the slow and fast forms of thrombin: evidence for folding transitions in the inhibitor and protease coupled to binding.
    Ayala YM, Vindigni A, Nayal M, Spolar RS, Record MT, Di Cera E.
    J Mol Biol; 1995 Nov 10; 253(5):787-98. PubMed ID: 7473752
    [Abstract] [Full Text] [Related]

  • 13. Stability of hirudin, a thrombin-specific inhibitor. The structure of alkaline-inactivated hirudin.
    Chang JY.
    J Biol Chem; 1991 Jun 15; 266(17):10839-43. PubMed ID: 2040604
    [Abstract] [Full Text] [Related]

  • 14. Kinetic mechanism for the interaction of Hirulog with thrombin.
    Parry MA, Maraganore JM, Stone SR.
    Biochemistry; 1994 Dec 13; 33(49):14807-14. PubMed ID: 7993908
    [Abstract] [Full Text] [Related]

  • 15. The hirudin-binding site of human alpha-thrombin. Identification of lysyl residues which participate in the combining site of hirudin-thrombin complex.
    Chang JY.
    J Biol Chem; 1989 May 05; 264(13):7141-6. PubMed ID: 2496126
    [Abstract] [Full Text] [Related]

  • 16. The structural elements of hirudin which bind to the fibrinogen recognition site of thrombin are exclusively located within its acidic C-terminal tail.
    Chang JY, Ngai PK, Rink H, Dennis S, Schlaeppi JM.
    FEBS Lett; 1990 Feb 26; 261(2):287-90. PubMed ID: 2107100
    [Abstract] [Full Text] [Related]

  • 17. Structural basis of RGD-hirudin binding to thrombin: Tyr3 and five C-terminal residues are crucial for inhibiting thrombin activity.
    Huang Y, Zhang Y, Zhao B, Xu Q, Zhou X, Song H, Yu M, Mo W.
    BMC Struct Biol; 2014 Dec 20; 14():26. PubMed ID: 25526801
    [Abstract] [Full Text] [Related]

  • 18. Deciphering the structural elements of hirudin C-terminal peptide that bind to the fibrinogen recognition site of alpha-thrombin.
    Chang JY.
    Biochemistry; 1991 Jul 09; 30(27):6656-61. PubMed ID: 2065053
    [Abstract] [Full Text] [Related]

  • 19. A new class of potent thrombin inhibitors that incorporates a scissile pseudopeptide bond.
    DiMaio J, Ni F, Gibbs B, Konishi Y.
    FEBS Lett; 1991 Apr 22; 282(1):47-52. PubMed ID: 2026264
    [Abstract] [Full Text] [Related]

  • 20. Probing the distance between the two binding sites of hirudin for its interaction with the active site and the fibrin(ogen)-binding site of alpha-thrombin.
    Wagner U, Schmitz T, Otte M, Dodt J.
    Biomed Biochim Acta; 1991 Apr 22; 50(4-6):707-10. PubMed ID: 1801747
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 17.